U-VTRS

Q:VTRS - VIATRIS INC - https://www.viatris.com

21:13:17 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
VTRS - Q	1.0	11.40	·	11.64	0.4	11.47	-0.08	-0.7	6,540.9	73,985	21,447	11.55 11.65 11.36	13.6175 8.74	19:57:35	Apr 16	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 21447

More trades...

Time ET	Ex	Price	Change	Volume
19:57:35	Q	11.51	-0.04	9
19:54:16	Q	11.32	-0.23	9
19:45:45	Q	11.32	-0.23	7
19:45:45	Q	11.32	-0.23	1
19:32:07	Q	11.47	-0.08	2
18:41:43	Q	11.52	-0.03	15
18:26:50	Q	11.40	-0.15	662
17:58:55	Q	11.43	-0.12	12
17:42:03	Q	11.43	-0.12	69
16:52:36	Q	11.47	-0.08	1,675,877

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2024-04-16 16:30	U:VTRS	News Release200	Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
2024-04-15 08:00	U:VTRS	News Release200	Viatris Appoints Corinne Le Goff as Chief Commercial Officer
2024-04-15 06:59	U:VTRS	News Release200	Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone(TM) 20 mg/mL Once-Daily in Canada
2024-04-01 07:15	U:VTRS	News Release200	Ocuphire Announces the U.S. Commercial Launch of RYZUMVl(TM) (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
2024-04-01 06:59	U:VTRS	News Release200	Viatris Announces the Launch of RYZUMVl(TM) (Phentolamine Ophthalmic Solution) 0.75% in the United States

Date ET

Symbol

Type

Headline

2024-04-16 16:30

U:VTRS

News Release

Viatris to Report First Quarter 2024 Financial Results on May 9, 2024

2024-04-15 08:00

U:VTRS

News Release

Viatris Appoints Corinne Le Goff as Chief Commercial Officer